Publisher Correction: Altered perivascular fibroblast activity precedes ALS disease onset

doi:10.1038/s41591-021-01414-6

Published Erratum

. 2021 Jul;27(7):1308.

doi: 10.1038/s41591-021-01414-6.

Publisher Correction: Altered perivascular fibroblast activity precedes ALS disease onset

Anna Månberg^#¹, Nathan Skene^#^{2

3

4}, Folkert Sanders⁵, Marta Trusohamn², Julia Remnestål¹, Anna Szczepińska⁵, Inci Sevval Aksoylu⁵, Peter Lönnerberg², Lwaki Ebarasi⁶, Stefan Wouters⁵, Manuela Lehmann⁷, Jennie Olofsson¹, Inti von Gohren Antequera⁵, Aylin Domaniku⁵, Maxim De Schaepdryver⁸, Joke De Vocht⁹, Koen Poesen^{8

10}, Mathias Uhlén^{11

12}, Jasper Anink¹³, Caroline Mijnsbergen¹³, Hermieneke Vergunst-Bosch¹⁴, Annemarie Hübers^{15

16}, Ulf Kläppe¹⁷, Elena Rodriguez-Vieitez¹⁸, Jonathan D Gilthorpe⁷, Eva Hedlund¹², Robert A Harris⁵, Eleonora Aronica¹³, Philip Van Damme⁹, Albert Ludolph^{15

19}, Jan Veldink¹⁴, Caroline Ingre^{17

20}, Peter Nilsson¹, Sebastian A Lewandowski^{21

22}

Affiliations

¹ Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.
² Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
³ Division of Neuroscience, Department of Brain Sciences, Imperial College London, London, UK.
⁴ United Kingdom Dementia Research Institute, London, UK.
⁵ Department of Clinical Neuroscience, Karolinska Institute, Centre for Molecular Medicine, Karolinska Hospital, Stockholm, Sweden.
⁶ Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
⁷ Department of Integrative Medical Biology, Umeå University, Umeå, Sweden.
⁸ Laboratory for Neurobiomarker Research, Department of Neurology, Leuven Brain Institute, KU Leuven (University of Leuven), Leuven, Belgium.
⁹ Neurology Department and Center for Brain & Disease Research, KU Leuven, VIB, Leuven, Belgium.
¹⁰ Laboratory Medicine, UZ Leuven (University Hospital Leuven), Leuven, Belgium.
¹¹ Division of Systems Biology, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.
¹² Department of Neuroscience, Karolinska Institute, Stockholm, Sweden.
¹³ Department of (Neuro)Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
¹⁴ UMC Utrecht Brain Center, University Medical Center Utrecht, Department of Neurology, Utrecht University, Utrecht, the Netherlands.
¹⁵ University of Ulm, Neurology Clinic, Ulm, Germany.
¹⁶ Division of Neurology, Geneva University Hospital, Geneva, Switzerland.
¹⁷ Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
¹⁸ Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
¹⁹ Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Bonn, Germany.
²⁰ Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
²¹ Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden. sebastian.lewandowski@ki.se.
²² Department of Clinical Neuroscience, Karolinska Institute, Centre for Molecular Medicine, Karolinska Hospital, Stockholm, Sweden. sebastian.lewandowski@ki.se.

^# Contributed equally.

PMID: 34079107
DOI: 10.1038/s41591-021-01414-6

Published Erratum

Publisher Correction: Altered perivascular fibroblast activity precedes ALS disease onset

Anna Månberg et al. Nat Med. 2021 Jul.

. 2021 Jul;27(7):1308.

doi: 10.1038/s41591-021-01414-6.

Authors

Affiliations

¹ Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.
² Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
³ Division of Neuroscience, Department of Brain Sciences, Imperial College London, London, UK.
⁴ United Kingdom Dementia Research Institute, London, UK.
⁵ Department of Clinical Neuroscience, Karolinska Institute, Centre for Molecular Medicine, Karolinska Hospital, Stockholm, Sweden.
⁶ Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
⁷ Department of Integrative Medical Biology, Umeå University, Umeå, Sweden.
⁸ Laboratory for Neurobiomarker Research, Department of Neurology, Leuven Brain Institute, KU Leuven (University of Leuven), Leuven, Belgium.
⁹ Neurology Department and Center for Brain & Disease Research, KU Leuven, VIB, Leuven, Belgium.
¹⁰ Laboratory Medicine, UZ Leuven (University Hospital Leuven), Leuven, Belgium.
¹¹ Division of Systems Biology, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.
¹² Department of Neuroscience, Karolinska Institute, Stockholm, Sweden.
¹³ Department of (Neuro)Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
¹⁴ UMC Utrecht Brain Center, University Medical Center Utrecht, Department of Neurology, Utrecht University, Utrecht, the Netherlands.
¹⁵ University of Ulm, Neurology Clinic, Ulm, Germany.
¹⁶ Division of Neurology, Geneva University Hospital, Geneva, Switzerland.
¹⁷ Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
¹⁸ Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
¹⁹ Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Bonn, Germany.
²⁰ Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
²¹ Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden. sebastian.lewandowski@ki.se.
²² Department of Clinical Neuroscience, Karolinska Institute, Centre for Molecular Medicine, Karolinska Hospital, Stockholm, Sweden. sebastian.lewandowski@ki.se.

^# Contributed equally.

PMID: 34079107
DOI: 10.1038/s41591-021-01414-6

No abstract available

PubMed Disclaimer

Erratum for

Altered perivascular fibroblast activity precedes ALS disease onset.
Månberg A, Skene N, Sanders F, Trusohamn M, Remnestål J, Szczepińska A, Aksoylu IS, Lönnerberg P, Ebarasi L, Wouters S, Lehmann M, Olofsson J, von Gohren Antequera I, Domaniku A, De Schaepdryver M, De Vocht J, Poesen K, Uhlén M, Anink J, Mijnsbergen C, Vergunst-Bosch H, Hübers A, Kläppe U, Rodriguez-Vieitez E, Gilthorpe JD, Hedlund E, Harris RA, Aronica E, Van Damme P, Ludolph A, Veldink J, Ingre C, Nilsson P, Lewandowski SA. Månberg A, et al. Nat Med. 2021 Apr;27(4):640-646. doi: 10.1038/s41591-021-01295-9. Epub 2021 Apr 15. Nat Med. 2021. PMID: 33859435 Free PMC article.

Cited by

The Multifaceted Neurotoxicity of Astrocytes in Ageing and Age-Related Neurodegenerative Diseases: A Translational Perspective.
Bouvier DS, Fixemer S, Heurtaux T, Jeannelle F, Frauenknecht KBM, Mittelbronn M. Bouvier DS, et al. Front Physiol. 2022 Mar 17;13:814889. doi: 10.3389/fphys.2022.814889. eCollection 2022. Front Physiol. 2022. PMID: 35370777 Free PMC article. Review.

Publication types

Actions

Grants and funding

MR/T04327X/1/MRC_/Medical Research Council/United Kingdom

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Publisher Correction: Altered perivascular fibroblast activity precedes ALS disease onset

Affiliations

Publisher Correction: Altered perivascular fibroblast activity precedes ALS disease onset

Authors

Affiliations

Erratum for

Similar articles

Cited by

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources

Miscellaneous